5’-transfer RNA halve-lysine-CTT as a promising biomarker for early detection of hepatocellular carcinoma

Figure 6 5’-transfer RNA halve-lysine-CTT promotes hepatocellular carcinoma cell proliferation and migration in vitro. A: 5-ethynyl-2’-deoxyuridine staining was used to evaluate the proportion of proliferating cells in MHCC97-H and Hep3B cells following transfection with 5’-transfer RNA halve-lysine-CTT mimic, mimic negative control, inhibitor or inhibitor negative control; B: Transwell assay was performed to evaluate the effect of 5’-transfer RNA halve-lysine-CTT on the migration capacities of MHCC97-H and Hep3B cells. All the values are as mean ± SD. ^aP < 0.01; ^bP < 0.001. tiRNA: Transfer RNA halve; Lys: Lysine; NC: Negative control; EDU: 5-ethynyl-2’-deoxyuridine.